Calgary, Canada
NanoTess, founded in 2020, is a promising player in the Biotechnology and Health Care sectors, headquartered in Canada. The company is dedicated to "creating new frontiers of opportunity through catalytic innovation, beginning with skin and wound healing," according to their slogan.
As a social enterprise, NanoTess leverages advanced technology to address unmet medical needs, specifically focusing on skin and wound healing solutions. Their approach not only aims to improve patient outcomes but also seeks to drive scalable innovation in the healthcare industry.
NanoTess recently secured a Venture Round investment on 01 January 2023, with Aventrock leading the investment. This infusion highlights investor confidence in NanoTess's potential to impact the biotech space.
For investors, NanoTess stands out as a strategic opportunity to participate in a socially conscious venture, promising both impactful healthcare results and potential financial returns.
